RayStation 10.1
by RaySearch Laboratories AB (PUBL)
510(k) K210645
Active
Valid until
No expiry
FDA recalls
5 ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK210645 | Date29 Jun 2021 | StatusActive |
Official records
- FDA 510(k) database K210645
From the FDA record
- Received by the FDA
- 3 Mar 2021
- FDA decision
- 29 Jun 2021 (Substantially Equivalent)
- FDA review time
- 118 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Recalls
-
- Ongoing Z-1102-2026
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
-
- Ongoing Z-2490-2025
DICOM SOP Instance UID and Series Instance UID from RayGateway, i.e. the interface to Accuray's iDMS, are not guaranteed to be unique.
-
- Ongoing Z-1188-2025
Inconsistency in the use of Density uncertainty in the RayStation functions Robust optimization, Robust evaluation and Compute perturbed dose for proton and light ion treatment plans when a HU-to-mass density CT calibration curve used in RayStation version 4.5 to 2024B including some service packs.
-
- Ongoing Z-1747-2024
Potential for reported SSD to be too high.
-
- Ongoing Z-1482-2024
A use error that has occurred with RayStation/RayPlan, where material override using Silicon, Si, was incorrectly selected for a silicone gel polymer implant.
-
- Terminated Z-0848-2022
If the dynamic jaw mode is used and an optimization is continued after changing the dose grid or modifying the target ROI, the positions of the jaws may change unexpectedly for some control points. User must be aware to avoid unnecessary jaw openings during treatment planning
Timeline
- Cleared FDA 510(k) K210645
- Recall initiated FDA recalls Z-0848-2022
- Recall initiated FDA recalls Z-1482-2024
- Recall initiated FDA recalls Z-1747-2024
- Recall initiated FDA recalls Z-1188-2025
- Recall initiated FDA recalls Z-2490-2025
- Recall initiated FDA recalls Z-1102-2026
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MUJ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.5050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
RayStation 10.1 is a Radiation Therapy Treatment Planning System designed for advanced radiotherapy planning. It integrates multi-criteria optimization and adaptive therapy capabilities to support external beam therapy, brachytherapy, and particle therapy (including protons, helium, and carbon ions). The system facilitates precise dose calculations and treatment planning across diverse radiation modalities, enhancing treatment accuracy and customization for complex cases.
This software-based system is intended for use in radiology departments and oncology centers, where it aids clinicians in generating optimized treatment plans. Supplied as a standalone software solution, it requires compatible hardware and network infrastructure for operation. The device holds FDA 510(k) clearance (K210645) under the Radiology advisory committee, classified as a Class II medical device under regulation 892.5050. No sterility or single-use requirements apply, as it is a reusable digital platform.
Similar devices
Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).
- VariSeed (v10) by Varian Medical Systems, Inc
- AI Segmentation by Varian Medical Systems, Inc.
- Radiance V3 by Gmv Soluciones Globales Internet S.A.U.
- EXPLORER 4D TREATMENT PLANNING SYSTEM by American Radiosurgery, Inc.
- Radiance V5 Radiation Therapy Planning System by Gmv Soluciones Globales Internet S.A.U.
- Precision Treatment Planning System by Accuray Incorporated
- HELAX-TMS V 5.1 RADIATION THERAPY TREATMENT PLANNING SYSTEM by Mds Nordion, Inc.
- MODEIFICATION TO IPLAN RT DOSE by Brainlab AG
- Eclipse Treatment Planning System v16.0 by Varian Medical Systems, Inc.
- OPTIRAD by Permedics, Inc.